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Background: Socioeconomic differences in survival after melanoma may be due to late diagno-
sis of the disadvantaged patients. The aim of the study was to examine the association between 
educational level, disposable income, cohabitating status and region of residence with stage at 
diagnosis of melanoma, including adjustment for comorbidity and tumor type.
Methods: From The Danish Melanoma Database, we identified 10,158 patients diagnosed 
with their first invasive melanoma during 2008–2014 and obtained information on stage, 
localization, histology, thickness and ulceration. Sociodemographic information was retrieved 
from registers of Statistics Denmark and data on comorbidity from the Danish National Patient 
Registry. We used logistic regression to analyze the associations between sociodemographic 
factors and cancer stage.
Results: Shorter education, lower income, living without partner, older age and being male 
were associated with increased odds ratios for advanced stage of melanoma at time of diagnosis 
even after adjustment for comorbidity and tumor type. Residence in the Zealand, Central and 
Northern region was also associated with advanced cancer stage.
Conclusion: Socioeconomically disadvantaged patients and patients with residence in three 
of five health care regions were more often diagnosed with advanced melanoma. Initiatives to 
increase early detection should be directed at disadvantaged groups, and efforts to improve 
early diagnosis of nodular melanomas during increased awareness of the Elevated, Firm and 
Growing nodule rule and “when in doubt, cut it out” should be implemented. Further studies 
should investigate regional differences in delay, effects of number of specialized doctors per 
inhabitant as well as differences in referral patterns from primary to secondary health care 
across health care regions.
Keywords: melanoma, cancer stage, sociodemographic factors, comorbidity, Denmark, early 
cancer detection
Introduction
The incidence of melanoma in Denmark has increased with over 4% per year during 
the past 25 years and by 2012, the yearly incidence was ~30 per 100,000 person-
years.1 Melanoma is the fourth and sixth most common cancer type, respectively, in 
women and men in Denmark.2 Despite a higher incidence rate among persons with 
higher socioeconomic position, lower socioeconomic position has been associated 
with poorer survival in this patient group,3–5 and we need to know more about where 
in the cancer pathway these survival disparities occur. A possible explanation is 
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delayed diagnosis in patients with lower socioeconomic 
position, and more knowledge is needed in order to detect 
cancer early in all patient groups and to identify groups at 
high risk of delayed diagnosis.
A late diagnosis may result in advanced cancer stage at 
time of diagnosis, and hypothesized explanations are delay 
in recognizing symptoms of the cancer, delayed health care 
seeking or later referral to specialized care among patients 
with lower socioeconomic position. The presence of other 
chronic disease, which is more frequent among patients 
with lower socioeconomic position, may influence timing 
of cancer diagnosis either through an increased observation 
because of more frequent health care contacts due to the 
health condition in question or conversely by decreasing 
individual resources in order to manage further health prob-
lems. Histological type of the tumor may also be differentially 
distributed according to socioeconomic group because some 
tumor types occur mainly among people with a certain life-
style or risk behavior in relation to sun exposure.
Furthermore, patients with lower socioeconomic position 
also tend to live in more rural rather than urban areas, where 
access to health care services may be lower.
Several studies have shown that patients living in neigh-
borhood areas with lower socioeconomic position tended 
to be diagnosed at a later stage of melanoma.4 Besides 
results from two Swedish studies,6,7 evidence is sparse from 
nationwide, population-based studies about the effect of 
individual level socioeconomic factors, such as education and 
income, on stage of cancer in melanoma patients. The role 
of comorbidity has only rarely been investigated, and only a 
few studies have looked at major geographical differences 
in combination with the socioeconomic factors.
This study presents results from Denmark where most 
primary and secondary health care services including all 
cancer treatments are tax-paid and thereby free of charge, 
with the aim of minimizing differential access to diagnosis 
and treatments. A referral from primary to secondary care 
is required, and the general practitioners play the role of 
gatekeepers to the rest of the health care system. Data are 
obtained from a nationwide Clinical Quality register with 
a coverage of ~95% of all Danish patients with melanoma 
in recent years8 and unique individual socioeconomic 
information from national administrative registers. The 
aim of the study was to investigate whether educational 
level, disposable income, cohabitating status or region of 
residence is associated with cancer stage and further to 
analyze the role of comorbidity and tumor type in these 
potential relations.
Methods
Study population
From the Danish Melanoma Database (DMD), we identified 
13,626 patients diagnosed with their first invasive melanoma 
between 2008 and 2014. DMD is a clinical register contain-
ing prospective and systematically collected data related to 
clinical observations, diagnostic procedures, tumor charac-
teristics, treatments and outcomes. It was established in 1985 
and now has a national coverage of ~93–96%.8
Clinical variables
Information on cancer T-, N- and M-stage; tumor location; 
histological subtype; tumor thickness; and ulceration was 
obtained from the DMD. The clinical stage at diagnosis was 
categorized according to AJCC’s 6th (2008–2013) and 7th 
edition (2013–2014),9,10 and for the analyses, cancer stage was 
divided into early (clinical stage I–IIA) and advanced-stage 
cancer (clinical stage IIB–IV). This cut-point is in accordance 
with the Danish follow-up program for melanoma, where 
stage IA is assessed as low-risk cancer and IB–IIA as inter-
mediate-risk cancer, while stage IIB–IV include the thickest 
tumors (stage IIB and IIC), with regional spread (stage III) or 
distant metastases (stage IV), all of which have the highest 
risk of relapse and dismal outcome.11 Tumors were grouped 
into histological subtypes: superficial spreading malignant 
melanoma, lentigo maligna melanoma, nodular melanoma, 
other and unknown/unclassified.
Data on comorbid conditions were obtained from the 
Danish National Patient Register, which is an administrative 
register containing data from all hospitalizations at somatic 
wards in Denmark since 1977.12 Diagnoses other than mela-
noma were retrieved, and the Charlson comorbidity index 
(CCI)13 was calculated. The CCI covers 19 selected condi-
tions with a score from 1 to 6 by degree of severity, and these 
conditions were summed from 10 years before and until 1 
year before date of the melanoma diagnosis. The CCI index 
was grouped into 0 (none), 1–2 and 3+.
Sociodemographic variables
Individual level sociodemographic factors were obtained by 
linking the unique personal identification number (assigned 
to all Danish residents) of the study population to the registers 
of Statistics Denmark, which contains data on each individual 
and is updated annually.14–16 We retrieved information on 
educational level, income and cohabiting status 1 year before 
diagnosis for each patient.
Education was divided into three categories based on 
Statistics Denmark’s recommendations of categorizing the 
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individual’s highest attained education level: short educa-
tion (7/9–12 years of basic or youth education), medium 
education (10–12 years of vocational education) and longer 
education (short, medium and longer higher education [>13 
years of education]).
Yearly disposable income per adult person in the house-
hold was calculated and categorized in to three groups 
based on quartiles of the disposable income per person 
in the population: 1st quartile (<150.708 Danish crowns 
[DKK]), 2nd–3rd quartile (150.708–279.715 DKK) and 
4th quartile (>279.715 DKK). Persons with high negative 
income (>50.000 DKK) were excluded from the analyses. 
One thousand DKK equals ~135 Euros.
Cohabiting status was defined as living with a partner 
(married or cohabiting) or living without a partner (single, 
widow/widower or divorced). Cohabiting was defined as, 
in the absence of marriage, two adults of the opposite sex, 
with a maximum age difference of 15 years, living at the 
same address and who have no family relation or with a 
mutual child.
Information about age, sex and region of residence was 
obtained from the Civil Registration System.16
From the study population, we excluded 105 patients 
because there was no match on any sociodemographic 
information, and further 178 persons were excluded because 
they had high negative income in Statistics Denmark’s reg-
isters. Further 328 patients under the age of 25 years were 
excluded as those persons might not have reached their final 
educational level. This yielded 13,015 patients (Table 1). For 
the adjusted analysis, 2,597 patients (20%) with missing 
Table 1 Disease and sociodemographic characteristics of 13,015 Danish melanoma patients diagnosed between 2008 and 2014
Characteristics Total Educational level
Short Middle Longer Unknown
N % N % N % N % N %
Sociodemographic factors
Age at diagnosis, years
25–34 1,034 8 252 7 270 6 468 11 44 12
35–44 1,900 15 345 9 682 14 849 20 24 7
45–54 2,174 17 470 13 868 18 806 19 30 8
55–64 2,651 20 665 18 1,097 23 862 21 27 7
65–74 2,939 23 953 26 1,184 25 766 18 36 10
75–84 1,677 13 721 20 585 12 336 8 35 10
85+ 640 5 255 7 141 3 76 2 168 46
Sex
Men 5,970 46 1,545 42 2,424 50 1,838 44 163 45
Women 7,045 54 2,116 58 2,403 50 2,325 56 201 55
Cohabiting status
Married or cohabiting 9,380 72 2,341 64 3,658 76 3,212 77 169 46
single, widow/widower or divorced 3,635 28 1,320 36 1,169 24 951 23 195 54
Educational level
Short 3,661 28 – – – – – – –
Medium 4,827 37 – – – – – – –
longer 4,163 32 – – – – – – –
Unknown 364 3 – – – – – – –
Disposable income
1st quartile 3,253 25 1,495 41 1,161 24 419 10 178 50
2nd–3rd quartile 6,508 50 1,691 46 2,711 56 1,949 47 157 43
4th quartile 3,254 25 475 13 955 20 1,795 43 29 8
Region of residence
Capital 5,171 40 1,270 35 1,723 36 1,998 48 180 49
Zealand 1,686 13 468 13 720 15 457 11 41 11
South 3,089 24 988 27 1,199 25 829 20 73 20
Central 2,014 15 598 16 769 16 604 15 43 12
North 1,055 8 337 9 416 9 275 7 27 7
Clinical factors
Cancer stage
ia 5,853 45 1,497 41 2,161 45 2,084 50 111 30
IB 2,040 16 582 16 742 15 659 16 57 16
(Continued)
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Characteristics Total Educational level
Short Middle Longer Unknown
N % N % N % N % N %
iia 723 6 234 6 274 6 195 5 20 5
IIB 450 3 163 4 165 3 97 2 25 7
iiC 228 2 88 2 76 2 35 1 29 8
iii 1,012 8 305 8 440 9 253 6 14 4
iV 112 1 43 1 44 1 21 1 4 1
Unclassified 394 3 108 3 140 3 137 3 9 2
Unknown 2,203 17 641 18 785 16 682 16 95 26
Tumor location
Head and neck 1,517 12 484 13 562 12 388 9 83 23
Front 1,593 12 370 10 630 13 559 13 34 9
Back 3,969 31 1,097 30 1,546 32 1,244 30 82 23
Limbs 4,968 38 1,434 39 1,715 36 1,689 41 130 36
Genitals 36 0 17 0 11 0 8 0 0 0
Unknown primary/unknown 932 7 259 7 363 8 275 7 35 10
Histological subtype
Superficial spreading malignant melanoma 9,464 73 2,517 69 3,511 73 3,201 77 235 65
Lentigo maligna melanoma 499 4 187 5 174 4 109 3 29 8
Nodular melanoma 1,101 8 370 11 429 9 262 6 40 11
Others 128 1 45 1 47 0 28 1 8 2
Unclassified or unknown 1,823 14 542 15 666 14 563 14 52 14
Tumor thickness, mm
≤1 7,733 59 2,047 56 2,825 59 2,693 65 168 46
1–2 2,204 17 646 18 839 17 665 16 54 15
>2 1,944 15 661 18 750 16 427 10 106 29
Not measurable 1,098 8 298 8 401 8 364 9 35 10
Missing 36 0 9 0 12 0 14 0 1 0
Tumor ulceration
Yes 1,369 11 484 13 512 11 293 7 80 22
no 10,338 79 2,792 76 3,826 79 3,466 83 254 70
Unknown 1,308 11 385 11 489 10 404 10 30 8
Comorbidity (CCIa)
none 9,983 77 2,632 72 3,657 76 3,460 83 234 64
1–2 2,278 18 764 21 884 18 539 13 91 25
3+ 754 6 265 7 286 6 164 4 39 11
Year of diagnosis
2008–2010 4,628 36 1,310 36 1,689 35 1,467 35 162 45
2011–2012 4,077 31 1,135 31 1,531 32 1,301 31 110 30
2013–2014 4,310 33 1,216 33 1,607 33 1,395 34 92 25
Total 13,015 100 3,661 28 4,827 37 4,163 32 364 3
Note: aCCI includes 19 selected diseases scored by degree of severity and summed to the CCI score.
Abbreviation: CCI, Charlson comorbidity index.
Table 1 (Continued)
TNM information or unclassifiable clinical stage and 260 
patients with unknown educational level were excluded, 
which resulted in a study group of 10,158 patients (Table 2).
Statistical analyses
The associations between socioeconomic and -demographic 
factors and cancer diagnosis stage were analyzed in a series 
of logistic regression models. First, the associations between 
sociodemographic factors and cancer stage were adjusted 
for age and sex. Second, the results were mutually adjusted 
for other sociodemographic factors, except for educational 
level, which was not adjusted for income, because income 
was hypothesized to be a clear mediator between education 
and cancer stage. Third, the model included additional adjust-
ment for tumor type and the fourth model also adjusted for 
comorbidity (CCI index).
Interactions between single socioeconomic variables with 
sex, age, comorbidity and localization of the tumor were 
tested one pair at a time with Wald test statistics. A signifi-
cant interaction existed between education and comorbidity 
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Table 2 Associations between socioeconomic and -demographic factors with cancer stage at diagnosis in 10,158 melanoma patients 
(ORs [95% CI]) for advanced vs. early cancera)
Characteristics Descriptive Adjusted models
Total N Advanced 
cancera N
Model 1 
Sex and age 
adjusted OR 
(95% CI)
Model 2 
Adjustedb +SEP 
factors OR (95% 
CI)
Model 3 
Adjustedc + 
tumor type OR 
(95% CI)
Model 4 
Adjustedd + 
comorbidity 
OR (95% CI)
Age at diagnosis, years
25–34 788 59 0.37 (0.28–0.49) 0.41 (0.31–0.55) 0.42 (0.31–0.57) 0.45 (0.33–0.60)
35–44 1,558 159 0.52 (0.43–0.63) 0.62 (0.51–0.76) 0.63 (0.51–0.78) 0.66 (0.53–0.82)
45–54 1,746 231 0.68 (0.57–0.81) 0.81 (0.67–0.97) 0.83 (0.68–1.00) 0.87 (0.71–1.05)
55–64 2,088 344 0.84 (0.72–0.99) 0.94 (0.80–1.11) 0.89 (0.75–1.06) 0.92 (0.77–1.09)
65–74 2,322 447 1.00 1.00 1.00 1.00
75–84 1,285 362 1.67 (1.42–1.96) 1.54 (1.31–1.82) 1.48 (1.28–1.82) 1.44 (1.20–1.72)
85+ 371 128 2.31 (1.82–2.93) 2.01 (1.57–2.57) 2.00 (1.52–2.62) 1.90 (1.45–2.50)
Sex
Women 5,494 772 1 1 1 1
Men 4,664 958 1.43 (1.28–1.59) 1.52 (1.36–1.69) 1.57 (1.40–1.77) 1.55 (1.38–1.74)
Educational level
longer 3,344 406 1 1 1 1
Medium 3,902 725 1.45 (1.27–1.66) 1.40 (1.22–1.60) 1.38 (1.20–1.60) 1.37 (1.19–1.59)
Short 2,912 599 1.53 (1.32–1.76) 1.50 (1.25–1.67) 1.41 (1.21–1.64) 1.40 (1.20–1.63)
Disposable income
4th quartile 2,625 303 1 1 1 1
2nd–3rd quartile 5,122 857 1.44 (1.25–1.67) 1.30 (1.12–1.51) 1.28 (1.09–1.50) 1.27 (1.08–1.49)
1st quartile 2,411 570 1.79 (1.51–2.11) 1.59 (1.33–1.89) 1.44 (1.19–1.74) 1.42 (1.17–1.71)
Cohabiting status
Married or cohabiting 7,388 1,175 1.00 1.00 1.00 1.00
single, widow/widower or divorced 2,770 555 1.25 (1.11–1.41) 1.27 (1.13–1.43) 1.25 (1.10–1.42) 1.24 (1.09–1.41)
Region of residence
Capital 4,170 589 1 1 1 1
Zealand 1,470 316 1.59 (1.36–1.86) 1.52 (1.30–1.78) 1.43 (1.21–1.70) 1.44 (1.22–1.71)
South 2,554 421 1.14 (0.99–1.31) 1.07 (0.93–1.23) 0.97 (0.84–1.13) 0.98 (0.84–1.14)
Central 1,305 263 1.46 (1.23–1.72) 1.42 (1.20–1.67) 1.21 (1.01–1.45) 1.22 (1.02–1.46)
North 659 141 1.58 (1.28–1.95) 1.47 (1.19–1.81) 1.21 (0.96–1.53) 1.22 (0.97–1.54)
Comorbidity (CCI indexe)
none 7,848 1,182 1.00 Not included Not included 1.00
1–2 1,754 385 1.15 (1.00–1.32) Not included Not included 1.17 (1.00–1.35)
3+ 556 163 1.54 (1.26–1.89) Not included Not included 1.54 (1.24–1.93)
Tumor histological type
Superficial spreading malignant melanoma 7,680 845 1.00 Not included 1.00 1.00
Lentigo maligna melanoma 278 13 0.26 (0.14–0.45) Not included 0.24 (0.13–0.42) 0.23 (0.13–0.41)
Nodular melanoma 848 477 9.52 (8.13–11.14) Not included 9.22 (7.86–10.80) 9.24 (7.88–10.83)
Others 106 53 7.32 (4.91–10.92) Not included 6.74 (4.49–10.11) 6.71 (4.47–10.06)
Unclassified or unknown 1,246 342 3.01 (2.60–3.49) Not included 2.91 (2.51–3.38) 2.92 (2.51–3.39)
Notes: aAdvanced cancer defined as TNM stage IIB–IV and early cancer defined as TNM stage I–IIA. bAdjustments as in model 1 and further mutually adjusted for SEP factors 
(educational level, disposable income, cohabiting status and region of residence). Only education is not adjusted for income, as this is considered a clear mediator of the 
association between education and cancer stage. cAdjustments as in model 2 and further adjusted for tumor histological type. dAdjustments as in model 3 and further adjusted 
for comorbidity (CCI). eCCI includes 19 selected diseases scored by degree of severity and summed to the CCI score.
Abbreviations: OR, odds ratio; CCI, Charlson comorbidity index; SEP, socioeconomic position.
with a higher effect of comorbidity on stage for patients with 
longer compared to short education; however, this was driven 
by a very small group of patients with long education level 
and comorbidity 3+ and therefore results were not stratified 
on this basis. There was an interaction between sex and 
cohabiting status; however, only borderline significant (P < 
0.07) and sex-stratified data are not shown.
Because data completeness was higher in 2013–2014 
(start of the DMD as a clinical quality register) than in 
2008–2012, we repeated the analyses including only these 
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two most recent years to assure that the interpretation of the 
results were close to what was found from analyzing the 
whole cohort.
In supplementary analyses, we repeated all the analy-
ses with the outcome variable clinical stage dichotomized 
into stage I vs II–IV in order to assure that results were the 
same even if the cut-point for early vs advanced cancer was 
changed. This yielded estimates that were close to what is 
reported in Table 2, and the interpretation of the results from 
the two categorizations was the same.
The analyses were carried out in SAS 9.4 with the PROC 
GENMOD procedure, and the level of significance was 
P < 0.05.
Ethics
Use of data for this project was approved by the Danish 
Health Authorities under the Capital Region of Denmark 
(J.no.: 2012-58-0004).
Results
The descriptive statistics in Table 1 show clinical and 
sociodemographic factors distributed according to the main 
exposure of interest: educational level. More patients with 
short compared to long education tended to have higher can-
cer stages, and thereby also thicker tumors and ulceration, 
and more short-educated patients had nodular malignant 
melanoma and comorbidity. Patients with shortest education 
also tended to have higher age, lower income, lived alone and 
outside the Capital Region.
Table 2 shows that patients with shorter education, 
with lower income, living without partner, with male sex, 
higher age, with comorbidity and who lived in the North-
ern, Central or Zealand region of Denmark had an elevated 
odds ratio (OR) of being diagnosed with advanced-stage 
cancer when adjusted for sex, age and sociodemographic 
factors. For example, the OR for advanced-stage cancer in 
patients with short compared to longest education was 1.50 
(1.25–1.67) and for lowest vs highest income level OR was 
1.59 (1.33–1.89), while OR for advanced cancer stage was 
1.52 (1.30–1.78) for patients living in Zealand compared to 
the Capital region (Table 2, model 2).
When adjusting for tumor type and comorbidity (Table 2, 
models 3 and 4, respectively), the ORs for advanced-stage 
cancer by socioeconomic and -demographic factors were 
only a little lower than the ORs in model 2, ie, for short vs 
longer education the adjusted OR was 1.40 (1.20–1.63) in 
the fully adjusted model. The estimates for region of resi-
dence were lower when adjusted for tumor type (model 3) 
than the confounder-adjusted estimates (model 2); however, 
this reduction in ORs was not found when restricting data 
to patients with diagnosis year 2013–2014 (data not shown).
Patients with high comorbidity burden had a higher OR of 
advanced cancer (comorbidity 3+ vs no comorbidity, adjusted 
OR = 1.54 [1.24–1.93]).
Discussion
The results of the present study showed that patients who 
were socially disadvantaged in terms of education, income 
or partner status had an increased risk of a diagnosis with 
advanced-staged melanoma. Region of residence was also 
associated with a higher risk of advanced stage when living 
in the Northern, Central or Zealand health care region. The 
effects of the socioeconomic factors seemed unexplained by 
differential distribution of comorbidity or tumor types among 
different socioeconomic groups.
It is an important finding that several different indicators of 
socioeconomic position were related to cancer stage at diag-
nosis, and this adds evidence to the current literature. Studies 
from USA, Europe and New Zealand consistently showed that 
patients living in neighborhood areas with lower socioeco-
nomic position tended to be diagnosed with a more advanced 
stage of melanoma.4,17–20 These studies were, however, based 
on socioeconomic measures at area level, with the risk of 
misclassification. Larger differences in health outcomes may 
be found in populations from USA because of an insurance-
based vs the mostly tax-based health care systems that exist 
in especially the Northern European countries, which should 
be considered when directly comparing inequality results. A 
nationwide population-based Swedish study with individually 
measured educational information reported a dose–response 
relation between three levels of education and disease stage 
with effect estimates close to our results.7 Besides this, a few 
other smaller studies linked data on individual level education 
to tumor thickness, which is a measure of locally advancement 
of the disease and reported short education and unemployment 
to be associated with thick tumors.4
Being married or living with a partner has earlier been 
associated with an early diagnosis of melanoma.4,21 In a 
nationwide population-based Swedish study, findings of 
advanced disease in single living were most pronounced 
among men.6 We found a similar trend of sex difference 
(data not shown), and especially men living without a partner 
seem to be a vulnerable group in terms of diagnostic delay.
A questionnaire study from USA on the link from 
socioeconomic position to advanced melanoma points to 
the following underlying reasons for such an association: 
patients with short education were more likely to believe that 
melanoma was not very serious, they had less knowledge of 
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skin symptoms of melanoma, they were less likely to have 
routinely examined their skin and to have ever been told by 
a physician that they had atypical moles or that they were 
at risk of skin cancer, or had been instructed by a physician 
how to look for signs of melanoma.22 However, results from 
older studies from the Northern Europe are conflicting on the 
association between socioeconomic position and knowledge 
and understanding of melanoma. Other studies indicate that 
higher socioeconomic position is associated with more use of 
specialist health care services in general,23 and a lower access 
to specialist dermatologist or specialized hospital treatment 
among patients with lower socioeconomic position could be 
an explaining factor for their delayed diagnosis.
Taking several socioeconomic factors into account, we 
found that patients with residency in three out of five geo-
graphical health care regions had a higher risk of advanced-
stage cancer. In a recent Swedish study, differences in stage 
distribution were found across smaller geographical areas,24 
and further in the population-based Swedish study, rural/other 
urban areas had higher melanoma-specific survival compared 
to metropolitan areas.7 Each of the five Danish Regions has 
responsibility for primary and secondary health care, and the 
organization of the referral to specialized care might thus 
be different between regions. Furthermore, the outer areas 
of Denmark have less primary and specialized doctors per 
inhabitant and longer distances to care. For instance, in the 
Zealand region, there is currently what corresponds to ~16 
specialized treatment centers for dermatology/plastic surgery 
compared to ~27 centers per 100,000 inhabitants in the Capital 
Region.25 That being said, region of residence may also be a 
mixture of unmeasured social factors and cultural/behavioral 
factors as well as a measure of organization of care.
Comorbidity did not seem to explain the socioeconomic 
difference in stage at diagnosis, although it was a significant 
independent risk factor for being diagnosed with advanced 
cancer. The findings point to lower awareness or decreased 
resources in terms of dealing with another health problem 
than the comorbid disorder. A similar association was found 
for melanoma screening in primary practice in France, where 
chronic disease was associated with non-participation.26 A 
Danish population-based study showed interaction between 
comorbidity and cancer stage with an increased mortality 
among patients with advanced melanoma and high comorbid-
ity,27 underlining the importance of a focus on comorbidity 
in detection and treatment of melanoma.
We adjusted the socioeconomic and geographical results 
for histological type of the cancer, because it was hypothesized 
that some tumor types occur mostly in groups of people with 
a certain lifestyle or risk behavior. Lentigo maligna melanoma 
and superficial spreading melanoma are related to sun expo-
sure, and sun habits could be speculated to change in a direc-
tion where more people from lower socioeconomic groups are 
exposed to sun or especially to use of sunbeds.23 However, it 
was found that more of the patients with longest education 
were diagnosed with superficial spreading malignant mela-
noma, whereas more patients with short education had nodular 
melanoma – even though the risk profile of nodular melano-
mas is primarily related to biology rather than behavior. As 
nodular melanomas are often fast growing and sometimes 
amelanotic, increased awareness hereof is crucial.28 Tumor 
type seemed to explain part of the geographical differences 
in cancer stage, but not when looking at the data solely from 
2013 to 2014. We suggest that missing data on tumor histology 
in the early study period drive the finding since a larger part 
with unknown/unclassified histology appeared in the North 
and Central regions (19 and 23%, respectively, for the whole 
study period vs 8% in the Capital Region, data not shown), 
which may bias the effect of tumor type.
Strengths of the current study include the population-
based data from both a clinical database and administrative 
registers, which minimize selection bias, information bias and 
misclassification of both exposure and outcome measures.
Limitations are some missing clinical data for patients diag-
nosed during the years 2008–2012 (before onset of the DMD 
as a Clinical Quality register); however, there was an equal 
distribution of missing/unclassified TNM stage in the groups 
of patients with lower and higher socioeconomic position. 
Furthermore, we checked that the main results were similar 
for the study period as a whole as for the years 2013–2014.
To measure comorbidity, we used the CCI with sum-
marized data of hospital diagnoses and therefore milder 
diseases not treated or followed up in hospital setting were 
not included. This may have resulted in some misclassifica-
tion with the risk of an underestimation of the true effect of 
comorbidity on outcome.
Another limitation is that we did not have information on 
contacts with primary practicing doctors, which could have 
pointed to some explanation of why there is a socioeconomic 
difference in cancer stage – patient’s delay in health care 
seeking or doctor’s delay in referral to specialized care. These 
relations should be further investigated in future studies.
The incidence of melanoma is increasing1 – an increase 
that has newly been shown across all socioeconomic groups, 
but with the highest increase of regional-distant disease 
among patients from the lowest socioeconomic areas in 
USA,29 and reducing socioeconomic and sex inequalities in 
stage at diagnosis would result in substantial reductions in 
deaths from melanoma.19
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Results from our study document important socioeco-
nomic and -demographic differences in stage at diagnosis. 
Initiatives should be directed to social disadvantaged groups, 
men and older people in order to increase awareness of symp-
toms of melanoma. In primary care, an increased attention 
should be paid to patients from these groups in order to dis-
cover skin changes or melanoma at an early stage. Additional 
efforts to improve early diagnosis of nodular melanomas 
would improve the early vs advanced ratio and thus have 
the potential to affect mortality significantly. The newly sug-
gested amendment to the diagnostic ABCD rule with EFG for 
Elevated, Firm and Growing nodule should be applied, and 
“when in doubt, cut it out” should be taught to both patients 
and doctors.28 Further studies should investigate regional 
differences in delay, effects of number of specialized doc-
tors per inhabitant as well as different referral patterns from 
primary to secondary health care across health care regions.
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